Skip to content

spatial region-resolved proteomic analysis of hippocampal sclerosis in drug-resistant temporal lobe epilepsy

spatial region-resolved proteomic analysis of hippocampal sclerosis in drug-resistant temporal lobe epilepsy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110323
Enrollment
Unknown
Registered
2025-10-11
Start date
2023-08-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

The brain tissue of hippocampus CA1 :None
The brain tissue of hippocampus CA2:None
The brain tissue of hippocampus CA3:None
The brain tissue of hippocampus CA4:None
The brain tissue of hippocampus DG:None
The brain tissue of hippocampus SUB:None

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1)Meet the definition criteria defined by the 2010 International League Against Epilepsy (ILAE): Drug resistant epilepsy. 2)The epileptogenic zone was identified as temporal lobe epilepsy through neuroimaging, EEG monitoring, or functional imaging. 3) Postoperative pathological analysis reveals hippocampal sclerosis. 4)Obtain the approval from the hospital ethics committee, and with the informed consent of patients before inclusion.

Exclusion criteria

Exclusion criteria: 1)The epileptogenic zone does not meet the criteria of temporal lobe epilepsy through neuroimaging, EEG monitoring, or functional imaging. 2)Postoperative pathological analysis reveals drug-resistant epilepsy caused by other etiologies such as tumors and cortical dysplasia. 3) The hippocampal formation of the brain sample is incomplete.

Design outcomes

Primary

MeasureTime frame
proteins of the fresh frozen hippocampal tissue ;

Countries

China

Contacts

Public ContactMei Liu

Affiliated Hospital of Zunyi Medical University

mayliu2019@126.com+86 180 8968 0011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026